Diagnostic Value of a Novel Junctional Cardiometabolic Index (NJCI) for Identifying Reduced Left Ventricular Ejection Fraction in Chinese Patients with Heart Failure: A Retrospective Observational Study
This retrospective study demonstrates that the Novel Junctional Cardiometabolic Index (NJCI) is a superior diagnostic biomarker compared to NT-proBNP for identifying reduced left ventricular ejection fraction in Chinese heart failure patients, exhibiting higher accuracy and serving as an independent predictor for risk stratification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart failure is a condition where the heart muscle becomes too weak to pump blood effectively throughout the body. It is a complex illness that does not just affect the heart; it creates a ripple effect that disturbs the liver, the blood's ability to clot, and the body's nutritional balance. For doctors, a critical piece of information is how well the heart's main pumping chamber is squeezing. This measure, known as the left ventricular ejection fraction, helps determine how severe the disease is and guides the choice of treatment. While ultrasound imaging is the standard way to measure this pumping strength, it requires specialized equipment and skilled operators, which are not always available. Because of this, researchers have long looked for simpler blood tests that could act as a reliable warning sign. One such test, measuring a substance called NT-proBNP, is currently the most common tool used, but it can sometimes be influenced by other factors like age or kidney function, making it less than perfect in every situation.
A team of researchers at the Fifth Affiliated Hospital of Xinjiang Medical University set out to see if they could create a better blood-based tool by combining several different signals from the body. They studied 338 patients who had already been diagnosed with heart failure. The researchers divided these patients into two groups based on their heart's pumping strength: those with a reduced ability to pump and those with a preserved, or normal, ability. To build their new tool, they looked at three specific things in the patients' blood: a marker for liver congestion, a marker for blood clotting activity, and a marker for nutrition and inflammation. They combined these three distinct pieces of information into a single score, which they named the Novel Junctional Cardiometabolic Index. The logic was that heart failure is a systemic problem involving multiple organs, so a test that looks at the liver, the blood, and the body's nutritional state all at once might tell a more complete story than a single test alone.
When the researchers compared their new score against the standard NT-proBNP test, the results were striking. The new index was far better at distinguishing between patients with weak heart pumping and those with normal pumping. In statistical terms, the new score had an AUC of 0.90 for identifying patients with reduced pumping strength, whereas the standard test had an AUC of 0.77. The patients with the weakest hearts consistently showed much higher values on this new combined score. Furthermore, the researchers found that this new score provided useful information even when they already knew a patient's NT-proBNP level. It acted as an independent predictor, meaning it could spot the severity of the heart failure on its own, regardless of the other test.
The study suggests that by weaving together signals of liver stress, blood clotting, and nutritional status, this new index captures the full complexity of heart failure better than looking at any single factor. The researchers noted that their work was limited to a specific group of patients in one hospital and was based on a single look at their data, so it cannot yet prove that the score causes the heart problems or predict future events. However, the findings indicate that this simple calculation, using blood tests that are already common in hospitals, could be a powerful addition to the doctor's toolkit. It offers a way to see the whole picture of a patient's condition, potentially helping to identify those with the most severe heart weakness more accurately than current methods allow.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.